Real-time Estimate
Tradegate
10:18:53 2024-06-07 am EDT
|
5-day change
|
1st Jan Change
|
109.6
EUR
|
-0.07%
|
|
+0.27%
|
+10.05%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
12,703
|
14,680
|
19,204
|
14,208
|
13,927
|
15,333
|
-
|
-
|
Enterprise Value (EV)
1 |
14,308
|
16,028
|
20,551
|
16,441
|
16,093
|
17,153
|
16,851
|
16,520
|
P/E ratio
|
43.2
x
|
48.8
x
|
48.3
x
|
50.8
x
|
40.8
x
|
33.9
x
|
29.7
x
|
26
x
|
Yield
|
1.01%
|
0.89%
|
0.78%
|
1.03%
|
1.1%
|
1.12%
|
1.23%
|
1.36%
|
Capitalization / Revenue
|
3.73
x
|
4.17
x
|
5.02
x
|
3.08
x
|
2.94
x
|
3.11
x
|
2.9
x
|
2.73
x
|
EV / Revenue
|
4.2
x
|
4.55
x
|
5.37
x
|
3.56
x
|
3.4
x
|
3.48
x
|
3.19
x
|
2.94
x
|
EV / EBITDA
|
20.2
x
|
21.6
x
|
25.2
x
|
17.8
x
|
17.8
x
|
17
x
|
15.3
x
|
13.9
x
|
EV / FCF
|
38.4
x
|
32.6
x
|
59.2
x
|
150
x
|
35.8
x
|
36.5
x
|
33.5
x
|
29.8
x
|
FCF Yield
|
2.6%
|
3.07%
|
1.69%
|
0.67%
|
2.79%
|
2.74%
|
2.99%
|
3.36%
|
Price to Book
|
5.28
x
|
6.38
x
|
5.71
x
|
4.46
x
|
3.92
x
|
3.88
x
|
3.56
x
|
3.25
x
|
Nbr of stocks (in thousands)
|
135,427
|
135,427
|
147,381
|
139,772
|
139,772
|
139,772
|
-
|
-
|
Reference price
2 |
93.80
|
108.4
|
130.3
|
101.6
|
99.64
|
109.7
|
109.7
|
109.7
|
Announcement Date
|
3/10/20
|
3/9/21
|
3/1/22
|
3/8/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
3,408
|
3,520
|
3,826
|
4,618
|
4,730
|
4,933
|
5,279
|
5,615
|
EBITDA
1 |
707
|
742
|
814
|
922
|
903.5
|
1,006
|
1,100
|
1,187
|
EBIT
1 |
464.2
|
487.5
|
559
|
630
|
611.2
|
707.7
|
792.1
|
872.1
|
Operating Margin
|
13.62%
|
13.85%
|
14.61%
|
13.64%
|
12.92%
|
14.35%
|
15%
|
15.53%
|
Earnings before Tax (EBT)
1 |
418.4
|
423.6
|
516
|
431.1
|
464.9
|
619.1
|
706.2
|
804.8
|
Net income
1 |
298.3
|
306.9
|
375
|
280
|
340.5
|
457.9
|
522.4
|
588.7
|
Net margin
|
8.75%
|
8.72%
|
9.8%
|
6.06%
|
7.2%
|
9.28%
|
9.89%
|
10.48%
|
EPS
2 |
2.170
|
2.220
|
2.700
|
2.000
|
2.440
|
3.239
|
3.697
|
4.211
|
Free Cash Flow
1 |
372.4
|
491.6
|
347.4
|
109.9
|
449.3
|
469.9
|
503.5
|
554.4
|
FCF margin
|
10.93%
|
13.97%
|
9.08%
|
2.38%
|
9.5%
|
9.53%
|
9.54%
|
9.87%
|
FCF Conversion (EBITDA)
|
52.67%
|
66.26%
|
42.68%
|
11.92%
|
49.73%
|
46.7%
|
45.77%
|
46.69%
|
FCF Conversion (Net income)
|
124.82%
|
160.21%
|
92.64%
|
39.26%
|
131.96%
|
102.63%
|
96.39%
|
94.18%
|
Dividend per Share
2 |
0.9500
|
0.9700
|
1.020
|
1.050
|
1.100
|
1.225
|
1.345
|
1.495
|
Announcement Date
|
3/10/20
|
3/9/21
|
3/1/22
|
3/8/23
|
3/6/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019 S2
|
2020 S1
|
2020 S2
|
2021 S1
|
2021 Q3
|
2021 Q4
|
2021 S2
|
2022 Q1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 Q2
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 S1
|
2025 S2
|
---|
Net sales
1 |
1,716
|
1,821
|
1,699
|
1,908
|
975.1
|
943
|
1,918
|
1,130
|
1,170
|
2,260
|
1,233
|
1,125
|
2,358
|
1,230
|
1,184
|
2,414
|
1,196
|
1,120
|
2,316
|
1,292
|
-
|
2,536
|
-
|
-
|
2,381
|
-
|
2,626
|
2,628
|
EBITDA
|
355.7
|
393.1
|
348.9
|
419.8
|
-
|
202.7
|
394.2
|
-
|
231.5
|
485.5
|
-
|
-
|
436.5
|
-
|
-
|
446
|
-
|
-
|
457.5
|
-
|
-
|
507
|
-
|
-
|
486
|
-
|
-
|
-
|
EBIT
|
232.6
|
265.8
|
221.7
|
296.6
|
-
|
138.1
|
262.4
|
-
|
160.8
|
344.2
|
-
|
-
|
285.8
|
-
|
-
|
311.4
|
-
|
-
|
299.8
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
13.56%
|
14.6%
|
13.05%
|
15.54%
|
-
|
14.64%
|
13.68%
|
-
|
13.75%
|
15.23%
|
-
|
-
|
12.12%
|
-
|
-
|
12.9%
|
-
|
-
|
12.94%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
236.9
|
186.7
|
273.6
|
-
|
121.3
|
242.4
|
-
|
158.8
|
317.7
|
-
|
-
|
113.4
|
-
|
-
|
257.7
|
-
|
-
|
207.2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
152.3
|
169.2
|
137.7
|
196.2
|
-
|
89.38
|
178.8
|
-
|
114.4
|
228.8
|
-
|
-
|
51.2
|
-
|
-
|
187.5
|
-
|
-
|
152.9
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
8.88%
|
9.29%
|
8.1%
|
10.28%
|
-
|
9.48%
|
9.32%
|
-
|
9.78%
|
10.12%
|
-
|
-
|
2.17%
|
-
|
-
|
7.77%
|
-
|
-
|
6.6%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
|
1.080
|
1.220
|
1.000
|
1.420
|
-
|
0.6400
|
1.280
|
-
|
0.8200
|
1.640
|
-
|
-
|
0.3600
|
-
|
-
|
1.340
|
-
|
-
|
1.100
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
1.050
|
-
|
-
|
-
|
-
|
-
|
1.100
|
1.100
|
-
|
-
|
-
|
-
|
1.150
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/10/20
|
8/6/20
|
3/9/21
|
8/5/21
|
10/26/21
|
3/1/22
|
3/1/22
|
5/2/22
|
8/2/22
|
8/2/22
|
10/26/22
|
3/8/23
|
3/8/23
|
5/2/23
|
8/2/23
|
8/2/23
|
12/6/23
|
3/6/24
|
3/6/24
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,605
|
1,348
|
1,347
|
2,233
|
2,166
|
1,820
|
1,518
|
1,187
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
2.27
x
|
1.817
x
|
1.655
x
|
2.422
x
|
2.397
x
|
1.809
x
|
1.38
x
|
1
x
|
Free Cash Flow
1 |
372
|
492
|
347
|
110
|
449
|
470
|
504
|
554
|
ROE (net income / shareholders' equity)
|
13.9%
|
13.1%
|
13.7%
|
12%
|
10.6%
|
12.2%
|
12.8%
|
13.3%
|
ROA (Net income/ Total Assets)
|
5.48%
|
5.16%
|
5.96%
|
5.62%
|
4.85%
|
5.88%
|
6.66%
|
7.4%
|
Assets
1 |
5,439
|
5,946
|
6,293
|
4,985
|
7,022
|
7,781
|
7,841
|
7,950
|
Book Value Per Share
2 |
17.80
|
17.00
|
22.80
|
22.80
|
25.40
|
28.30
|
30.80
|
33.70
|
Cash Flow per Share
2 |
3.930
|
4.600
|
3.730
|
2.580
|
5.150
|
4.790
|
5.440
|
6.400
|
Capex
1 |
174
|
144
|
174
|
250
|
270
|
268
|
280
|
288
|
Capex / Sales
|
5.12%
|
4.09%
|
4.55%
|
5.42%
|
5.71%
|
5.44%
|
5.31%
|
5.13%
|
Announcement Date
|
3/10/20
|
3/9/21
|
3/1/22
|
3/8/23
|
3/6/24
|
-
|
-
|
-
|
Last Close Price
109.7
EUR Average target price
113.7
EUR Spread / Average Target +3.62% Consensus |
1st Jan change
|
Capi.
|
---|
| +9.80% | 16.68B | | +21.26% | 68.69B | | -0.40% | 49.19B | | +23.56% | 44.73B | | +30.26% | 28.24B | | +7.71% | 19.22B | | -5.26% | 16.08B | | -23.26% | 15.62B | | -18.20% | 13.89B | | -21.84% | 13.44B |
Other Specialty Chemicals
|